High Glycated Albumin and Mortality in Persons with Diabetes Mellitus on Hemodialysis
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Monitoring of glycemic control with hemoglobin A1c (A1c) in hemodialysis patients may be compromised by anemia and erythropoietin therapy. Glycated albumin (GA) is an alternative measure of glycemic control but is not commonly used because of insufficient evidence of association to clinical outcomes. We tested whether GA measurements were associated with mortality in hemodialysis patients with diabetes mellitus. METHODS: The German Diabetes and Dialysis Study (4D) investigated effects of atorvastatin on survival in 1255 patients with diabetes mellitus receiving hemodialysis. We measured GA during months 0, 6, and 12. Cox proportional hazards analysis was used to measure associations between GA and A1c and all-cause mortality. RESULTS: Patients with high baseline GA (fourth quartile) had a 42% higher 4-year mortality compared to those in the first quartile (HR 1.42; 95% CI, 1.09–1.85, P = 0.009). Repeated measurements of GA during year one also demonstrated that individuals in the top quartile for GA (analyzed as a time-varying covariate) had a 39% higher 4-year mortality (HR 1.39; 95% CI, 1.05–1.85, P = 0.022). The associations between high A1c and mortality using similar analyses were less consistent; mortality in individuals with baseline A1c values in the 3rd quartile was increased compared to 1st quartile (HR 1.36; 95% CI, 1.04–1.77, P = 0.023), but risk was not significantly increased in the 2nd or 4th quartiles, and there was a less consistent association between time-varying A1c values and mortality. CONCLUSIONS: High GA measurements are consistently associated with increased mortality in patients with diabetes mellitus on hemodialysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
Wanner, C., Krane, V., März, W., Olschewski, M., Mann, J. F. E., Ruf, G., & Ritz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043545 · Cited by 2,614
Self-citationTahara, Y., & Shima, K. (1995) · Diabetes Care · doi:10.2337/diacare.18.4.440 · Cited by 380
Comparison of glycated albumin and hemoglobin A1c levels in diabetic subjects on hemodialysis
Peacock, T. P., Shihabi, Z. K., Bleyer, A. J., Dolbare, E. L., Byers, J. R., Knovich, M. A., Calles-Escandon, J., Russell, G. B., & Freedman, B. I. (2008) · Kidney International · doi:10.1038/ki.2008.25 · Cited by 323
Fructosamine and glycated albumin and the risk of cardiovascular outcomes and death
Selvin, E., Rawlings, A. M., Lutsey, P. L., Maruthur, N., Pankow, J. S., Steffes, M., & Coresh, J. (2015) · Circulation · doi:10.1161/circulationaha.115.015415 · Cited by 151 · cited 1×
“(19) Multiple clinical studies have observed that GA in patients on HD tends to be more strongly correlated with mean glucose concentrations compared to A1c.”
BackgroundFreedman, B. I., Shenoy, R. N., Planer, J. A., Clay, K. D., Shihabi, Z. K., Burkart, J. M., Cardona, C. Y., Andries, L., Peacock, T. P., Sabio, H., et al. (2010) · Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis · doi:10.3747/pdi.2008.00243 · Cited by 121
Relationship between assays of glycemia in diabetic subjects with advanced chronic kidney disease
Freedman, B. I., Shihabi, Z. K., Andries, L., Cardona, C. Y., Peacock, T. P., Byers, J. R., Russell, G. B., Stratta, R. J., & Bleyer, A. J. (2010) · American Journal of Nephrology · doi:10.1159/000287561 · Cited by 90
Berg, A. H., & Sacks, D. B. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.049205 · Cited by 41
Self-citationWilliams, M. E., Mittman, N., Ma, L., Brennan, J. I., Mooney, A., Johnson, C. D., Jani, C. M., Maddux, F. W., & Lacson, E. (2015) · Hemodialysis International · doi:10.1111/hdi.12312 · Cited by 30 · cited 1×
“(4, 5, 7, 32) In the present study, we observed similar trends, finding that the ratio of GA compared to A1c was higher in HD patients compared to participants with normal renal function.”
Result
Cited by
Zelnick, L. R., Batacchi, Z. O., Ahmad, I., Dighe, A., Little, R. R., Trence, D. L., Hirsch, I. B., & de Boer, I. H. (2020) · Diabetes Care · doi:10.2337/dc20-0915 · Cited by 55
Jung, M., Warren, B., Grams, M., Kwong, Y. D., Shafi, T., Coresh, J., Rebholz, C. M., & Selvin, E. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12618 · Cited by 43
“There is a large body of literature demonstrating a strong link between HbA1c and clinical complications, including in people with CKD.27–31 In randomized clinical trials, reducing HbA1c in people with CKD has been associated with fewer microvascular complications.32,33 There is a growing literature demonstrating the…”
BackgroundInfluentialCopur, S., Siriopol, D., Afsar, B., Comert, M. C., Uzunkopru, G., Sag, A. A., Ortiz, A., Covic, A., van Raalte, D. H., Cherney, D. Z., et al. (2021) · Acta Diabetologica · doi:10.1007/s00592-020-01581-x · Cited by 38
Metadata
- Authors
- Chen, C. W., Drechsler, C., Suntharalingam, P., Karumanchi, S. A., Wanner, C., & Berg, A. H.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-02-01
- Volume
- 63
- Issue
- 2
- Pages
- 477-485
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2530541894
- Cited by
- 56
- References
- 8
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High Glycated Albumin and Mortality in Persons with Diabetes Mellitus on Hemodialysis. https://app.cochat.ai/papers/10.1373/clinchem.2016.258319
- The paper
- Chen, C. W., Drechsler, C., Suntharalingam, P., Karumanchi, S. A., Wanner, C., & Berg, A. H. (2017). High Glycated Albumin and Mortality in Persons with Diabetes Mellitus on Hemodialysis. Clinical Chemistry. https://doi.org/10.1373/clinchem.2016.258319
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.